Effect of DMSO on Protein Structure and Interactions Assessed by Collision-Induced Dissociation and Unfolding by Chan, Daniel et al.
 Effect of DMSO on Protein Structure and Interactions As-
sessed By Collision-induced Dissociation and Unfolding 
Daniel S.-H. Chan,† Madeline E. Kavanagh,† Kirsty J. McLean,‡ Andrew. W. Munro,‡ Dijana 
Matak-Vinković,† Anthony G. Coyne,† and Chris Abell*,† 
†Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, United Kingdom) 
‡Centre for Synthetic Biology of Fine and Specialty Chemicals (SYNBIOCHEM), Manchester Institute of Biotech-
nology, School of Chemistry, The University of Manchester, Manchester M1 7DN, United Kingdom 
ABSTRACT: Given the frequent use of DMSO in biochemical and biophysical assays, it is desirable to understand the in-
fluence of DMSO concentration on the dissociation or unfolding behavior of proteins. In this study, the effects of DMSO 
on the structure and interactions of avidin and Mycobacterium tuberculosis (Mtb) CYP142A1 were assessed through colli-
sion-induced dissociation (CID) and collision-induced unfolding (CIU) as monitored by nanoelectrospray ionization-ion 
mobility-mass spectrometry (nESI-IM-MS). DMSO concentrations higher than 4% (v/v) destabilize the avidin tetramer 
towards dissociation and unfolding, via both its effects on charge state distribution (CSD) as well as at the level of indi-
vidual charge states. In contrast, DMSO both protects against heme loss and increases the stability of CYP142A1 towards 
unfolding even up to 40% DMSO. Tandem MS/MS experiments showed that DMSO could modify the dissociation path-
way of CYP142A1, while CIU revealed the protective effect of the heme group on the structure of CYP142A1.    
 
Over the past two decades, electrospray ionization-
mass spectrometry (ESI-MS) has emerged as a powerful 
technique to study biomolecular structure and function.1-2 
In particular, the ability of ESI-MS to generate macromo-
lecular ions from aqueous solution under relatively soft 
ionization energies has enabled the study of both non-
covalent protein-protein and protein-ligand complexes 
under native-like conditions.3-4 ESI-MS can moreover be 
interfaced with ion-mobility (IM) spectrometry, which 
separates gaseous ions by differences in their rotationally-
averaged collision cross-section (CCS), to provide an ad-
ditional dimension of resolution.5-6 
Native mass spectrometry is an ideal technique to in-
vestigate the effects of dimethyl sulfoxide (DMSO), a co-
solvent often included in biochemical and biophysical 
assays, on protein structure and interactions. Zenobi and 
co-workers reported that DMSO (0.5 to 8%) reduced the 
binding affinities of three protein-ligand complexes.7 In 
contrast, Landreh and co-workers found that 3% DMSO 
stabilized the tetrameric state of transthyretin (TTR) and 
its non-covalent interaction with the thyroid hormone 
thyroxine (T4), as well as the trimeric state of the C-
terminal domain of lung surfactant protein C (CTC) and 
its non-covalent interaction with a trivaline peptide.8 
Moreover, Williams and co-workers have investigated the 
effect of DMSO concentration on the structure and con-
formation of hen egg white lysozyme and equine myoglo-
bin using both ESI-MS and solution phase experiments.9 
Circular dichroism (CD) spectroscopy and hydrogen-
deuterium exchange (HDX) experiments suggested that 
the proteins underwent compaction at concentrations up 
to about 50%, followed by unfolding at higher concentra-
tions.9 In contrast, Tjernberg and co-workers have report-
ed that DMSO concentrations as low as 3% induced de-
stabilization, degradation and aggregation of the phos-
phatase domain of PFKFB1 (BPase) as revealed by both 
ESI-MS and solution assays.10 Recently, our group has 
shown that a small compaction of protein structure by 
DMSO could be detected in the gas phase by the use of 
ESI-IM-MS.11 
The internal energy of gaseous protein ions can be in-
creased by raising the acceleration voltages at different 
stages of the mass spectrometer. Through collisions with 
neutral gas molecules, multiprotein complexes acquire 
energy and can undergo dissociation (collision-induced 
dissociation, CID), which commonly takes place by the 
ejection of a highly-charged, unfolded monomeric subu-
nit through the asymmetric charge partitioning mecha-
nism.12-13 Moreover, activated protein ions can undergo 
unfolding (collision-induced unfolding, CIU), which can 
be tracked by monitoring their CCS as a function of colli-
sion energy.14-16 Previous studies mainly by the Ruotolo 
group have explored the effect of various cations and ions 
on the CID and CIU stabilities of model proteins.17-20 
However, to our knowledge, no systematic study on the 
effect of DMSO on protein CID or CIU behavior has yet 
been reported.  
In this study, avidin and CYP142A1 were chosen as rep-
resentative examples of proteins with quaternary struc-
ture or prosthetic groups, respectively. Avidin is a well-
 characterized glycoprotein found in the egg-white of 
birds and reptiles. The protein forms a multiprotein com-
plex that consists of four identical subunits assembled 
together in a dimer of dimers arrangement.21 In contrast, 
the Mycobacterium tuberculosis (Mtb) cytochrome P450 
enzyme CYP142A1 is predominantly monomeric and binds 
a heme-b prosthetic group. CYP142A1 functions as a cho-
lesterol oxidase and contributes to the ability of Mtb to 
establish a chronic infection.22-24  
Our work provides evidence that DMSO influences CID 
and CIU stability via a dual mechanism of charge modula-
tion as well as via charge state-independent effects. Addi-
tionally, we observe that the effects of DMSO on protein 
structure and interactions are highly protein-dependent, 
with CYP142A1 displaying unusual stability even at high 
DMSO concentrations. Finally, we use tandem MS/MS 
experiments to show that DMSO can influence the heme 
dissociation pathway of CYP142A1, and also demonstrate 
that the protective effects of the heme group on CYP142A1 
stability can be tracked using CIU, a technique that 
should be broadly applicable to other heme-containing 
proteins. 
□ EXPERIMENTAL SECTION 
Materials and Methods. Avidin (egg white), conca-
navalin A (Canavalia ensiformis), alcohol dehydrogenase 
(Saccharomyces cerevisiae) and pyruvate kinase (rabbit 
heart) were obtained from Sigma-Aldrich (St. Louis, MO, 
USA). Mtb His6-tagged CYP142A1 was expressed as previ-
ously described.22 Protein samples were exchanged into 
200 mM ammonium acetate (pH 7.0) solution using Mi-
cro Bio-Spin 6 chromatography columns (Bio-Rad, UK) 
and diluted to a final concentration of 20 μM (avidin) or 
10 μM (CYP142A1) before analysis. 
Mass Spectrometry. Nanoelectrospray ionization-ion 
mobility-mass spectrometry (nESI-IM-MS) was performed 
on a Synapt HDMS mass spectrometer (Waters, Manches-
ter, UK) modified for studying high masses and equipped 
with a traveling-wave (TW) IMS device. 2.5 μL of protein 
solution was injected into a gold-coated borosilicate emit-
ter (Thermo Scientific, UK) for sampling. Typical condi-
tions were: capillary voltage 1.5 kV, cone voltage 50 V, 
transfer collision voltage 12 V, source temperature 20 °C, 
backing pressure 3–4 mbar, trap pressure 3–4 × 10–2 mbar, 
IMS (N2) pressure 5–6 × 10–1 mbar and TOF pressure 7–8 × 
10–7 mbar. To effect CID and CIU, the trap collision volt-
age was raised in 5 V increments from 20 to 100 V for avi-
din and in 10 V increments from 20 to 150 V for CYP142A1. 
To record CIU, the instrument was operated in mobility 
TOF mode using an IMS wave velocity of 250 ms–1 and a 
wave height of 10 V. Avidin, concanavalin A, alcohol de-
hydrogenase and pyruvate kinase were used as calibrant 
ions for CCS determination. 
Data Processing. Mass spectra were calibrated exter-
nally using a solution of cesium iodide (100 mg mL–1). Da-
ta acquisition and processing were performed using 
MassLynx 4.1 (Waters) and DriftScope 2.5 (Waters). For 
CID analysis, the measured peak heights were used and 
all charge states were taken into account. CID50 values 
were calculated from non-linear curve fitting using Origin 
9.1 (OriginLab). PULSAR16 was used to calibrate CCS val-
ues,25 visualize CIU fingerprints and calculate CIU50 val-
ues. Unless otherwise stated, all CCS values are quoted as 
N2 values. CID50 and CIU50 values are quoted as mean ± 
standard deviation of at least two independent experi-
ments. 
As algorithms for CCS calculation from X-ray crystal 
structures are parameterized for helium collision gas,26 
the corresponding CCS(He) of CYP142A1 was also deter-
mined by calibration with helium CCS values in order to 
enable comparison between the experimental result and 
the theoretical CCS. The experimental CCS(He) of 
CYP142A1 was 3140 Å2, which is within 2% of the theoreti-
cal CCS(He)calc value of 3090 Å2, where CCS(He)calc = 1.14 × 
CCS(He)PA × (Mexp/MPDB)2/3 and CCS(He)PA is the CCS cal-
culated from the X-ray crystal structure of CYP142A1 
(PDB: 2XKR)22 using the projection approximation (PA) 
algorithm implemented in DriftScope, Mexp is the mass of 
His6-tagged CYP142A1 (47178 Da) used in the experiment 
and MPDB is the mass of the CYP142A1 construct (45015 
Da) in the reported crystal structure. The coefficient of 
1.14 in the above calculation is an empirically determined 
scaling factor that takes into account the underestimation 
of CCS by the PA algorithm due to its masking of the cavi-
ty slow-down effect.2, 26 
□ RESULTS AND DISCUSSION 
DMSO Affects The Charge of Protein Ions in the 
Gas Phase. The bimodal effect of DMSO on protein 
charging has been well-documented in the literature. At 
low concentrations, DMSO reduces protein charge, which 
has been attributed to a global compaction of protein 
structure in solution by the groups of Voets27 and Wil-
liams9 on the basis of CD spectroscopy, small-angle neu-
tron scattering, Rayleigh scattering and HDX-MS results. 
Our group has recently shown that the compaction of 
protein structure by DMSO can also be detected in the 
gas phase through the use of nESI-IM-MS, even at the 
level of individual charge states.11 At high DMSO concen-
trations, DMSO increases protein charge, which has been 
attributed to protein denaturation.28 However, to our 
knowledge, the use of nESI-IM-MS to study the effect of 
high DMSO concentrations on protein structure has not 
previously been reported. 
In this study, the effect of DMSO concentration on avi-
din and CYP142A1 under minimal activation conditions 
was first investigated. Concentrations of DMSO higher 
than 60% could not be examined due to aggregation of 
avidin, whereas for CYP142A1 the maximum DMSO con-
centration that could be tested was 40%. The tetrameric 
state of avidin was well-preserved at concentrations up to 
60% DMSO (Figure S1a). At 50 and 60% (v/v) DMSO, a 
small amount of monomeric avidin ions (16 kDa) could be 
 detected centered around the 9+ charge state. This result 
suggests that high concentrations of DMSO could induce 
the dissociation of avidin even under minimal activation 
conditions. 
For CYP142A1, the native mass spectra showed that 
CYP142A1 exists predominantly in monomeric form (Fig-
ure S2a), consistent with the reported X-ray crystal struc-
ture,22 and was centered around the 12+ charge state in 
the absence of DMSO. The protein remained monomeric 
as the DMSO concentration was increased to 40%. How-
ever, signals of individual charge states were broadened, 
which could be attributed to the adduction of small mole-
cules to the protein at higher DMSO concentrations. 
Moreover, CYP142A1 fully retained its heme moiety even 
at 40% DMSO, in contrast to a previous ESI-MS study of 
myoglobin in which 90% of heme was already lost at 20% 
DMSO.9 To our knowledge, this is the first reported study 
of CYP142A1 by native MS. 
The bimodal effect of DMSO on protein charge was also 
evident (Figures S1b and S2b). However, very high DMSO 
concentrations (50% for avidin and 40% for CYP142A1) 
decreased average charge slightly, similar to previously 
observed for lysozyme and myglobin.9 Intriguingly, the 
average charge of CYP142A1 reached at 30% or 40% 
DMSO was still lower than under DMSO-free conditions 
(Figure S2b), in contrast to avidin where supercharging 
was observed from 10% of DMSO (Figure S1b). To our 
knowledge, CYP142A1 is the first protein that has been 
reported to remain charge-reduced at such high DMSO 
concentrations. In a previous study, avidin, concanavalin 
A, alcohol dehydrogenase and pyruvate kinase were su-
percharged at DMSO concentrations greater than 10 or 
20%.11 Meanwhile, the onset of supercharging was around 
20% DMSO for lysozyme and myoglobin,9 while for BPase 
both supercharging and protein denaturation were evi-
dent at as little as 3% of DMSO.10 As DMSO is less volatile 
than water, electrospray droplets actually become en-
riched (estimated to be 3 to 5-fold9) in DMSO as they 
shrink. In concert with the IM-MS data (see below), our 
data suggest that CYP142A1 may remain compacted at 
DMSO concentrations even higher than 40% when in the 
gas phase. The reason for the remarkable gas-phase sta-
bility of CYP142A1 under such high DMSO concentrations 
is not known. 
DMSO Influences The Size of Individual Protein 
Charge States. IM-MS was also performed to assess the 
effect of DMSO concentration on the size of avidin and 
CYP142A1 ions. The weighted-average CCS of CYP142A1 at 
0% DMSO was within 2% (see Experimental Section) of 
the theoretical CCS predicted from the X-ray crystal 
structure (PDB: 2XKR),22 suggesting that CYP142A1 re-
tained its native structure in the gas phase. The abun-
dance-weighted average CCS of avidin tetramers de-
creased from 4080 Å2 without DMSO to 4010 Å2 at 4% 
DMSO (Figure S1b), while for CYP142A1 the CCS de-
creased from 3450 Å2 without DMSO to 3240 Å2 at 20% 
DMSO (Figure S2b). This is consistent with the compac-
tion of protein structure at low DMSO concentrations as 
shown previously by IM-MS11 or solution-phase tech-
niques.9, 27  
Increasing the DMSO concentration beyond 4% led to 
an increase in average CCS for avidin, initially mirroring 
the trend for average charge (Figure S1b). However, the 
two trends deviated at higher DMSO concentrations, with 
CCS continuing to rise as the DMSO concentration was 
increased beyond 40%, even while average charge de-
creased. The maximal CCS of avidin tetramers (4240 Å2) 
was reached at 60% DMSO. This CCS was 4% larger than 
the average size of ions in the absence of DMSO (4080 
Å2), and 6% larger than the compacted avidin ions at 4% 
DMSO (4010 Å2). For CYP142A1, the change in average 
CCS of CYP142A1 ions generally paralleled the trend for 
charge, except that the minimum CCS (3240 Å2) was 
reached at 20% DMSO, instead of at 4% DMSO for mini-
mum charge (Figure S2b). Moreover, the average CCS at 
40% DMSO (3350 Å2) was still 3% lower than that in the 
absence of DMSO, suggesting that the overall structure of 
CYP142A1 was still compacted even at the highest DMSO 
concentration used. 
To investigate whether the change in CCS at higher 
DMSO concentrations could be related to conformational 
changes of individual ions, the CCS of individual charge 
states were plotted against DMSO concentration. Higher 
DMSO concentrations generally increased the CCS of 
individual avidin charge states, with the exception of 4% 
DMSO where a minimum in CCS was observed (Figures 
S3a). Individual charge states of CYP142A1 were also com-
pacted by DMSO, with minimum CCS values being 
reached at 20% DMSO for all charge states (Figure S3b). 
These data therefore suggest that DMSO could induce 
expansion or compaction of avidin and CYP142A1 ions, 
respectively, even at the level of individual charge states. 
We hence propose that the increase in average CCS of 
avidin induced by DMSO (Figure S1b) could arise from a 
combination of two factors. Firstly, the supercharging 
effect of DMSO allows avidin ions to access higher charge 
states that are also larger due to increased Coulombic 
repulsion. Secondly, DMSO causes expansion in the size 
of individual charge states, which is presumably related to 
its denaturing ability. Conversely, DMSO is proposed to 
reduce the average CCS of CYP142A1 (Figure S2b) both as 
consequence of its ability to shift the charge state distri-
bution (CSD) of CYP142A1 to lower charge, as well as its 
ability to compact protein structure at the level of indi-
vidual charge states. 
 DMSO Modulates the CID Stability of Proteins and 
Influences the Heme Dissociation Pathway of 
CYP142A1. Several research groups have studied the effect 
of DMSO on the stability of non-covalent interactions by 
ESI-MS. In one study, DMSO (0.5 to 8%) weakened the 
stability of three different protein-ligand complexes, 
which was attributed to the ability of DMSO to destabi-
lize the protein and perturb the ligand-binding pocket, 
interfere with the ligand, or act as a competing inhibitor.7 
In contrast, another study reported a protective effect of 
DMSO (3%) on both the quaternary structure of multi-
protein complexes and their interaction with small mole-
cule or peptide ligands, which was attributed to a combi-
nation of charge reduction and a cooling effect from ad-
duct dissociation.8 However, no systematic study has 
been performed on the effect of high concentrations of 
DMSO on the CID stability of protein structure and inter-
actions in the literature. 
In this study, avidin tetramers underwent CID at higher 
trap collision voltages (CV) to generate highly charged, 
unfolded monomers and “stripped” trimers (Figure 1a). In 
the absence of DMSO, ~50% of the tetramer was dissoci-
ated at a trap CV of 65 V. Moreover, higher charge states 
of avidin became depleted first as the collision voltage 
was raised, which could be attributed to increased Cou-
lombic repulsion. When DMSO was added, the overall 
CID pathway did not change and similar distributions of 
monomers and trimers were produced (Figure 1b shows 
CID spectra at 60% DMSO). However, dissociation was 
facilitated by higher DMSO concentrations. For instance, 
in the absence of DMSO, 77% of the tetramer was pre-
served at a CV of 60 V, whereas with 60% DMSO, only 
17% of the tetramer remained intact at the same CV. Plot-
ting the abundance of the tetramer as a function of CV 
(Figure 1c) reveals that DMSO concentrations higher than 
4% promoted tetramer dissociation. The Figure 1c inset 
presents CID50 values (the CV needed to dissociate 50% 
of tetramers) as a function of DMSO concentration. The 
CID50 of avidin tetramers increased from 66.5 to 78.1 V 
(+11.6 V) as the DMSO concentration was raised from 0 to 
4%, indicating a protective effect against dissociation. 
However, further increase in the DMSO concentration led 
to a decrease in CID50, with the minimum CID50 value of 
53.6 V being reached at 50% DMSO, corresponding to a 
decrease of 12.9 V compared to in the absence of DMSO. 
In summary, our data show that high concentrations of 
DMSO have a significant destabilizing effect on the CID 
of avidin. Only at 4% DMSO, where the average charge of 
the avidin tetramer was lowest, did DMSO have a protec-
tive effect against subunit dissociation.  
Generally, the CID50 values of avidin were inversely re-
lated to average protein charge. That is, DMSO concen-
trations that produced higher average charges of the avi-
din tetramer also gave lower overall CID50 values. There-
fore, it was also of interest to determine whether the de-
stabilization of avidin tetramers by DMSO was due solely 
to the ability of DMSO to shift the CSD of avidin tetram-
ers towards higher charge, or whether DMSO also exerted 
destabilizing effects on individual ions that are independ-
ent of its effect on CSD. To address this, the CID50 values 
for the individual charge states were plotted as a function 
of DMSO concentration (Figure S4a). Interestingly, 
DMSO also promoted the dissociation of individual 
charge states. For example, the CID50 of the 16+ charge 
state was lowered from 1043 to 954 eV (–89 eV) when the 
DMSO concentration was raised from 0 to 60%, while for 
the 17+ charge state a reduction from 1020 to 923 eV (–97 
eV) in CID50 was observed upon increasing DMSO con-
centration from 20 to 60%. This is in contrast to previous-
ly reported results from Landreh and co-workers, where 
3% DMSO had no effect on the CID stability of the 16+ 
charge state of TTR.8 However, our study used relatively 
high concentrations of DMSO, compared to the 3% 
DMSO used for TTR. Indeed, the protective effect of 4% 
DMSO against dissociation could not be detected at the 
level of individual charge states in our study (Figure S4a). 
Taken together, the overall reduction in the CID stability 
of avidin at high DMSO concentrations could be attribut-
ed to two, possibly interrelated, mechanisms. First, 
DMSO shifts the CSD of avidin tetramers towards ions of 
higher charge, which have lower intrinsic stability against 
dissociation. Second, DMSO may also exert a destabiliz-
ing effect against individual charge states, presumably as 
a consequence of its denaturing effect.  
Figure 1. DMSO influences the CID stability of avidin. Na-
tive MS spectra of avidin in the presence of a) 0% or b) 60% 
DMSO at different trap CVs. The abundance of the tetramer 
(%Tet) at each CV is indicated. c) Abundance of tetramer as 
a function of trap CV at each DMSO concentration. The inset 
shows the CID50 as a function of DMSO concentration. 
 The influence of DMSO on the CID behavior of 
CYP142A1 was also investigated. Figures 2a and 2b show 
CID spectra of CYP142A1 at 0 and 30% DMSO, respective-
ly. CYP142A1 holoenzyme underwent CID to release the 
apoenzyme and also the free heme-b ion at m/z 616 Da 
([M]+) together with an ammonia adduct of heme-b at 
m/z 633 Da ([M+NH3]+). The CYP142A1 peaks also gener-
ally became sharper at higher CV, consistent with the 
dissociation of buffer and/or DMSO molecules from the 
protein. Interestingly, DMSO had a protective effect 
against heme loss. For instance, only 20% of CYP142A1 
ions retained heme at 140 V in the absence of DMSO 
(Figure 2a), whereas in the presence of 30% DMSO, the 
proportion of the holoenzyme was 37% (Figure 2b). 
Among all DMSO concentrations tested, heme dissocia-
tion occurred earliest at 0% DMSO (Figure 2c), with a 
CID50 value (the CV needed to dissociate 50% of holoen-
zyme) of 117.7 V (Figure 2c inset). The highest stability of 
the holoenzyme was observed at 4% DMSO (CID50 = 
137.9 V), with stability decreasing as the DMSO concen-
tration was increased further.  
As with avidin, it was also of interest to explore whether 
DMSO could protect against dissociation of the heme 
group in a manner that is independent of its effects on 
CSD. To study this issue further, tandem MS/MS was per-
formed to study the dissociation pathways of individual 
charge states. In the absence of DMSO, CYP142A1 ions 
exhibited two heme dissociation pathways: charge strip-
ping and charge retention (Figure 3a). In the charge strip-
ping pathway, the holo-CYP142A1 N+ ion dissociates into 
the heme monocation and the (N – 1)+ ion of the apoen-
zyme. This is the anticipated dissociation pathway for 
CYP142A1 because the protein is expressed in the ferric 
(3+) oxidation state, and therefore would be expected to 
dissociate the (Fe(III)heme)+ ion.29 In contrast, in the 
charge retention pathway, the liberated apoenzyme has 
the same charge as the initial holoenzyme, which is pre-
sumed to occur via the dissociation of a neutral heme 
species, possibly a heme-acetate adduct.30 However, at 
30% DMSO, the charge retention pathway is eliminated 
and only the charge stripping pathway is observed (Figure 
3b). We reason that the much higher concentration of 
DMSO (ca. 4.2 M) relative to acetate (200 mM) causes the 
anionic acetate to be displaced from heme in the initial 
solution through the formation of a (heme-DMSO)+ ad-
duct,31-32 thereby eliminating the charge retention path-
way. In contrast, avidin tetramers exhibited only a minor 
amount of charge stripping before dissociation (Figure 
S5).  
The MS/MS data also confirmed that higher charge 
states of CYP142A1 dissociated heme more easily than 
lower charge states, as expected (Figures 3c and S6a). 
Moreover, DMSO conferred a protective effect against 
heme-b loss even at the level of individual charge states. 
For instance, the CID50 values of the 11+ and 12+ charge 
states increased from 1297 ± 13 eV to 1421 ± 18 V (+124 eV) 
and from 1277 ± 17 eV to 1354 ± 16 eV (+77 eV) respectively 
as the DMSO concentration was raised from 0 to 30% 
(Figure 3c inset). Taken together, these data suggest that 
DMSO protects against heme loss both by shifting the 
CSD of CYP142A1 towards ions of lower charge, which 
have higher intrinsic stability to dissociation, as well as by 
enhancing the stability of individual charge states. The 
latter effect could be linked to the compaction of 
CYP142A1 ions by DMSO concentrations, that is, more 
compact holoenzymes have a greater resistance against 
heme loss.  
Figure 2. DMSO influences the CID stability of CYP142A1. 
Native MS spectra of CYP142A1 in the presence of a) 0% or 
b) 30% DMSO at different trap CVs. The proportion of holo-
CYP142A1 (%Holo) at each CV is indicated. c) Proportion of 
holo-CYP142A1 as a function of trap CV at each DMSO con-
centration. The inset shows the CID50 as a function of 
DMSO concentration. 
  DMSO Modulates the CIU Stability of Proteins. A 
number of studies have investigated the effect of various 
solution additives on the CIU stability of different pro-
teins. The Ruotolo group have shown that both anions17 
and cations18 can have dramatic effects on both CIU and 
CID stabilities. It was postulated that anions stabilize pro-
teins through dissociative cooling-type mechanisms, 
whereas cations increase stability by forming multiden-
tate interactions within proteins to tether together non-
contiguous protein regions.19 Robinson, Ruotolo and co-
workers have found that TrisH+ also increased CIU stabil-
ity, which was attributed to an evaporative cooling mech-
anism or alternatively to the binding of TrisH+ to critical 
regions of the protein so as to replace solvent contacts 
that are needed for maintaining native-like confor-
mations.20 However, to our knowledge, the effect of 
DMSO on the CIU stability of proteins has not yet been 
reported in the literature.  
Figure 3. DMSO influences the dissociation pathway of 
CYP142A1. Tandem MS/MS of CYP142A1 at a) 0% DMSO and 
b) 30% DMSO with selection of the 12+ holoenzyme (left 
panel) or 11+ holoenzyme (right panel) as the precursor ion 
(indicated by a filled red circle). The trap CV and proportion 
of holo-CYP142A1 (%Holo) at each CV is indicated. c) Pro-
portion of holo-CYP142A1 as a function of trap CV at 0 or 
30% DMSO for 11+ and 12+ charge states. The inset shows the 
CID50 for the 11+ and 12+ charge states at 0 and 30% DMSO. 
Figure 4. DMSO affects the CIU stability of avidin. CIU fin-
gerprints of avidin tetramer charge states in the presence of 
a) 0% or b) 50% DMSO. c) CIU50 values for the 15+, 16+ and 
17+ charge states at 0 and 50% DMSO. 
 Figure 4a shows CIU fingerprints for the 14+ to 17+ 
charge states of the avidin tetramer in the absence of 
DMSO. At least three less compact conformations in ad-
dition to the native conformation were observed at 0% 
DMSO for the 15+ charge state of avidin, which was simi-
lar to previously reported.19-20 Higher charge states of the 
avidin tetramer unfolded at lower CV, which can again be 
attributed to increased Coulombic destabilization. Un-
folding pathways for the avidin tetramer were broadly 
similar in the presence of 50% DMSO (Figure 4b). How-
ever, lower voltages were needed to unfold avidin ions of 
a given charge state at 50% DMSO compared to in the 
absence of DMSO. For instance, the CIU50 (energy need-
ed to deplete 50% of the most compact conformation) 
value of the 15+ ion of the avidin tetramer decreased from 
786 ± 11 eV in the absence of DMSO to 744 ± 17 V (–42 eV) 
with 50% DMSO (Figures 4c and S4b). However, the de-
creases in CIU50 induced by DMSO are comparatively 
smaller than the reductions of CID50 described previously 
(Table S1), indicating that DMSO has a greater destabiliz-
ing effect on tetramer dissociation than unfolding. 
The collision energy differences between CID50 and 
CIU50 were invariably positive (Figure S4c), indicating 
that all charge states of the avidin tetramer undergo un-
folding before dissociation, consistent with the asymmet-
ric protein dissociation hypothesis. The magnitudes of 
these differences were comparable to a previous CID/CIU 
study on avidin by Ruotolo and co-workers.33 Moreover, 
at DMSO concentrations between 0 and 30%, the colli-
sion energy difference generally increased with charge 
state, similar to previous observations.33 As both CID and 
CIU values decrease with charge, this suggests that Cou-
lombic repulsion has a larger destabilizing effect on un-
folding compared to dissociation. However, the collision 
energy differences were generally reduced at high DMSO 
concentrations (≥40%). For example, the collision energy 
difference for the 16+ charge state of avidin was decreased 
from 404 ± 40 eV at 20% DMSO to 313 ± at 31 eV at 60% 
DMSO. This observation is consistent with the greater 
ability of DMSO at promote dissociation compared to 
unfolding of individual charge states, as noted above.  
CIU fingerprints for the 10+ to 13+ charge states of the 
CYP142A1 holoenzyme at 0 and 30% DMSO are shown in 
Figures 5a and 5b, respectively. As with avidin, CYP142A1 
holoenzymes transitioned through progressively more 
extended conformers as the CV was increased, with the 
exception of the 10+ ion which exhibited only two con-
formational states (compact and extended) over the range 
of CV tested. Unlike with avidin, however, DMSO in-
creased the stability of CYP142A1 ions against unfolding. 
For instance, the CIU50 value of the 11+ holoenzyme in-
creased from 650 ± 15 eV at 0% DMSO to 696 ± 9 V (+46 
eV) at 30% DMSO (Figures 5c and S6b). Thus, and in sim-
ilar fashion to its effect on CID stability, it is proposed 
that DMSO increases the stability of CYP142A1 holoen-
zymes against unfolding both by reducing the average 
charge of the ions, as well as by increasing the CIU stabil-
ity at the level of individual charge states. However, the 
increases in CIU50 induced by DMSO are relatively small 
compared to the increases of CID50 described above (Ta-
ble S1).  Figure S6c plots the collision energy differences 
between CID50 and CIU50 for different charge states of 
the CYP142A1 holoenzyme. As with avidin, CYP142A1 hol-
oenzymes generally unfold before dissociating, and the 
collision energy differences at lower charge states were 
also reduced. This is consistent with the observation that 
DMSO has a greater protective effect on CID compared to 
CIU, as noted above. 
The unfolding behavior of the ejected CYP142A1 apoen-
zyme was also tracked. CIU fingerprints of the apoen-
zymes were similar in the absence (Figure S7a) or pres-
ence of 30% DMSO (Figure S7b). At 30% DMSO, the 9+ 
apoenzyme was ejected in a compact state (CCS = 3060 
Å2) that did not unfold even at the highest CV tested. The 
ejected 10+ apoenzyme was also initially compact (CCS = 
Figure 5. DMSO affects the CIU stability of CYP142A1. CIU 
fingerprints of CYP142A1 holoenzyme charge states in the 
presence of a) 0% or b) 30% DMSO. c) CIU50 values for the 
10+, 11+ and 12+ charge states at 0 and 30% DMSO. 
 3180 Å2), but transitioned to an extended conformation 
(CCS = 3620 Å2) at voltages beyond 90 V. These CCS val-
ues are similar to those for the compact and extended 
states of the 10+ holoenzyme at the same CV (CCS = 3200 
and 3640 Å2 respectively), indicating that the loss of the 
heme group did not have a major effect on the size of ei-
ther the compact or extended conformations of CYP142A1. 
The 11+ to 13+ charge states of the apoenzyme were eject-
ed in extended states.  
Monitoring the Protective Effect of the Heme 
Group using CIU. The heme prosthetic group is known 
to stabilize the structure of heme-containing proteins, 
including cytochrome P450s.34 Using ultraviolet photodis-
sociation (UVPD) mass spectrometry, Brodbelt and 
Cammarata showed that the cleavage of holo-myoglobin 
was suppressed in regions that interact with heme, indi-
cating that the heme had a protective effect against frag-
mentation.35 Williams and co-workers found that the 
heme group protected against the DMSO-induced unfold-
ing of myoglobin by solution-phase HDX-MS experi-
ments.9 Intriguingly, the stabilizing effect of the heme 
group on the unfolding stability of CYP142A1 could also be 
monitored by CIU. For instance, at 0% DMSO, the CIU50 
value for the 10+ holoenzyme was 947 ± 3 eV, but this 
decreased to 852 ± 2 eV (–95 eV) for the 10+ apoenzyme 
(Figure S7c). Similarly, at 30% DMSO the CIU50 value for 
the 10+ holoenzyme (1079 ± 20 eV) was 204 eV higher 
than for the 10+ apoenzyme (875 ± 14 eV). These results 
indicate that the heme group substantially stabilizes the 
CYP142A1 holoenzyme in the gas phase. However, while 
high DMSO concentrations protected against the unfold-
ing of the holoenzyme, it had little effect on the unfolding 
stability of the corresponding apoenzyme (Figure S7d).  
□ CONCLUSIONS 
Native nESI-IM-MS has been used to study the effect of 
DMSO on the dissociative and unfolding stability of avi-
din and Mtb CYP142A1. To our knowledge, this is the first 
systematic study of the effect of DMSO on protein CID 
and CIU in the literature. There are a number of general 
conclusions from our work.  
We have provided evidence that suggests a dual mech-
anism for the ability of DMSO to modulate the CID and 
CIU stability of proteins. DMSO not only shifts the CSD 
of proteins to higher or lower charge states, which vary in 
intrinsic stability due to differences in electrostatic repul-
sion, but also modulates stability via effects at the level of 
individual charge states.  
Our data also show that the effects of DMSO on protein 
structure and interactions are highly protein-dependent, 
which has implications for the design of biological assays 
where DMSO is frequently employed as a co-solvent. 
While DMSO concentrations higher than 4% facilitated 
the dissociation and unfolding of the avidin tetramer, 
CYP142A1 exhibited remarkable stability in the presence 
of up to 40% DMSO, which protected the enzyme from 
both heme loss and unfolding. To our knowledge, 
CYP142A1 is the first protein that has been reported to 
remain charge-reduced at such high DMSO concentra-
tions in native MS. However, compared to previous work 
with ions,17-19 the stabilizing effects of DMSO on CYP142A1 
are comparatively weaker. This could be due to the fact 
that as DMSO is neutral, it interacts relatively weakly 
with protein, and hence less energy is removed when 
DMSO adducts dissociate from the protein. 
Additionally, we have established using tandem MS/MS 
experiments that DMSO could modify the heme dissocia-
tion pathway of CYP142A1. In the absence of DMSO, 
CYP142A1 can dissociate either the positive (Fe(III)-
heme)+ ion or the neutral (Fe(III)heme)–acetate adduct, 
resulting in charge stripping and charge retention, respec-
tively. However, DMSO is hypothesized to displace ace-
tate, such that only the charge stripping pathway is ob-
served in the presence of DMSO. Finally, we have demon-
strated that the protective effects of the heme group on 
the gas-phase stability of CYP142A1 can be assessed using 
CIU. We envisage that this approach could be broadly 
applied to study the stabilizing effect of heme or other 
prosthetic groups on other proteins in the gas phase.    
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